STAT3 and STAT5A are potential therapeutic targets in castration-resistant prostate cancer

Mechanisms of castration-resistant prostate cancer (CRPC) are not well understood, thus hindering rational-based drug design. Activation of STAT3/5A, key components of the JAK/STAT pathway, is implicated in aggressive PC, yet their clinical relevance in CRPC remains elusive. Here, we evaluated the p...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Mohanty, Sambit K., Yagiz, Kader, Pradhan, Dinesh, Luthringer, Daniel J., Amin, Mahul B., Alkan, Serhan, Cinar, Bekir
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2017
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5689662/
https://ncbi.nlm.nih.gov/pubmed/29156772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20844
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller